Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of erythropoietin stimulating agent on quality of life in non-dialysis ESRD patients
TCTR20231103005Phase 4Completed
- Sponsor
- Phayao Hospital
- Start
- Oct 2022
- Countries
- 1
01
Overview
Phase 4 trial in end-stage kidney disease (ESKD) and anemia of renal disease, sponsored by Phayao Hospital. Primary endpoint: quality_of_life_change. Started Oct 2022; status: completed.
02
Conditions
end-stage kidney disease (ESKD)anemia of renal disease
Beyond the preview
Go deeper on TCTR20231103005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231103005.